Wednesday, 18 May, 2022
TopicFavipiravir

Topic: favipiravir

India’s second wave sees Covid drug FabiFlu sales jump 600% in April to rake in Rs 351 crore

FabiFlu replaced multivitamin drug Zincovit as the top selling drug as India witnessed the highest number of Covid infections, hospitalisations and deaths in April.

What’s on our minds in peak pandemic? ‘Oxygen’, ‘plasma’ and ‘remdesivir’, says Google

Indian social media has been inundated with posts about Covid — from availability or lack of oxygen and hospital beds to treatment options. What an analysis of Google Trends found.

Remdesivir, favipiravir sales zoom to record Rs 1,000 crore in 7 months in Covid year

Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.

Modi govt panel rejects proposal to make chewable Favipiravir tablets for Covid patients

Committee didn’t find MacLeods Pharma’s proposal adequate, but is considering US firm Mylan’s proposal to test Favipiravir with three other drugs.

Test efficacy of umifenovir alone as Covid drug, not with favipiravir — govt panel to Macleods

Mumbai-based Macleods Pharmaceuticals had sought permission to conduct clinical trials on umifenovir, a Russian drug used to treat influenza.

Govt panel rejects Glenmark proposal to test Covid drug favipiravir with steroid dexamethasone

Modi govt's subject expert committee rejects Glenmark's proposal by highlighting that its justifications to conduct trials of favipiravir with dexamethasone were 'not adequate'.

Cipla, Optimus get nod for phase 4 trials to check efficacy of Covid drug favipiravir

Study will note clinical improvement of Covid patients & assess safety of favipiravir. It will also see ‘mortality, disease progression & viral clearance’ at given stages.

Zenara Pharma latest Indian firm to get nod for ‘Covid drug’ favipiravir, to call it Favizen

Touted as a potential Covid treatment, favipiravir tablets to be sold by Zenara Pharma, a subsidiary of Biophore, will be manufactured in Hyderabad.

Covid patients given favipiravir showed ‘40% faster’ recovery, Glenmark trial results claim

Glenmark conducted phase 3 clinical trials of favipiravir on 150 mild to moderate Covid patients. Adverse events, or side effects, reported in 32 patients.

Favipiravir cheapest in India, false claims hurting reputation — Glenmark tells Modi govt

The pharma company came under the scanner after the DCGI sent a letter based on a representation by an MP.

On Camera

YourTurn

File photo of Assi Ghat, Varanasi | Representative Image | Neera Majumdar | ThePrint

Forget Gyanvapi for a moment, Varanasi needs justice for a recent carnage: 2006 IM bombings

The real victim of the Varanasi bombing investigation has been the idea of justice. It's more lethal than any bombs the Indian Mujahideen planted.
File image of Tata Group's headquarters in Mumbai | Photo: Dhiraj Singh | Bloomberg

Tata in acquisition talks with as many as 5 brands, to bolster position in consumer goods sector

The conglomerate will likely face stiff competition in the sector from existing global giants such as Unilever, as well as Indian tycoon Mukesh Ambani’s Reliance Industries.

Defence

Satellite image of the development on the site | Twitter | @detresfa_

China building ‘bigger, broader’ 2nd bridge at Pangong Tso that can carry armoured columns

China's People's Liberation Army aims for multiple routes to counter any possible operations by the Indian forces on the southern banks of the Pangong Tso in the future.

How Congress is like the Ambassador & why Indian politics needs a brand new set of wheels

Like the car, nothing the party has done to reinvent itself has worked. Only way forward is to offer something looking towards the future, not in image of glorious past.
×